NIKKEI 225
37,097.90 -981.80 (-2.58%) HANG SENG
16,204.66 -181.21 (-1.11%) CRUDE OIL
84.44 +1.71 (+2.07%) GOLD FUTURES
2,398.60 +0.60 (+0.03%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
50,041.97 +359.88 (+0.72%)
CollPlant Biotechnologies Ltd. (CLGN)
After hours:
| Previous close | 5.25 |
| Open | 5.21 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.10 - 5.24 |
| 52-week range | 4.22 - 8.90 |
| Volume | |
| Avg. volume | 7,680 |
| Market cap | 59.792M |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.62 |
| Earnings date | 22 May 2024 - 27 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.00 |
PR NewswireCOLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.
PR NewswireCOLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen, today announced that it will report financial results for the full year of 2023 on Thursday, April 4, 2024, before the market open. The Company will then host a conference call and webcast to discuss its financial results and corporate updates on April 4th at 10:00 am Eastern Daylight Time.
Simply Wall St.Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago
If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough...
